Codexis and Matrix Laboratories enter into partnership for development and commercialization of novel process
Advertisement
Codexis announced it has signed an agreement with Matrix Laboratories (Matrix), a leading provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry, for the development and commercialization of the API for a high-value pharmaceutical product.
Codexis will employ its proprietary pharmaceutical process re-engineering technology platform to develop a novel synthetic process for the product via a Codexis Thoroughbred(TM) biocatalyst. The process will be transferred to Matrix for scale-up and manufacturing. Under the terms of the collaboration, Codexis will receive research and development funding, milestone payments and a royalty on net sales of the product. Matrix will receive exclusive manufacturing and marketing rights to the novel process. Further financial terms were not disclosed.
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
New guideline for synthesis of fullerene electron acceptors
TIG1
Plastic upcycling: From waste to fuel for less - Problem plastics could be diverted from landfills and converted into fuel sources with new technology
Molecular manganese complex as superphotooxidant - Scientists developed a new molecular system made from the abundant element manganese for photooxidations
CONSTRUCCIONES INOX LASAOSA, S.L. - La Muela, Zaragoza, Spain
Izon Science Ltd - Christchurch, New Zealand
Ametek GmbH - Meerbusch, Germany
Brenntag Argentina S.A. - Buenos Aires, Argentina